Flagship Harbor Advisors’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-70
Closed -$14K 1012
2025
Q4
$14K Buy
+70
New +$12.7K ﹤0.01% 1427
2025
Q1
Sell
-1,282
Closed -$237K 754
2024
Q4
$237K Buy
+1,282
New +$247K 0.01% 643
2024
Q3
Sell
-1,142
Closed -$236K 730
2024
Q2
$236K Sell
1,142
-500
-30% -$113K 0.01% 609
2024
Q1
$445K Sell
1,642
-150
-8% -$35.8K 0.03% 414
2023
Q4
$424K Sell
1,792
-20
-1% -$3.93K 0.03% 397
2023
Q3
$355K Hold
1,812
0.03% 427
2023
Q2
$381K Buy
1,812
+591
+48% +$118K 0.03% 418
2023
Q1
$246K Buy
1,221
+70
+6% +$15.9K 0.02% 537
2022
Q4
$251K Buy
+1,151
New +$251K 0.03% 518
2020
Q4
Sell
-348
Closed -$78K 774
2020
Q3
$78K Hold
348
0.01% 729
2020
Q2
$60K Buy
348
+30
+9% +$4.79K 0.01% 796
2020
Q1
$40K Hold
318
0.01% 816
2019
Q4
$49K Hold
318
0.01% 813
2019
Q3
$42K Hold
318
0.01% 824
2019
Q2
$45K Buy
318
+181
+132% +$24.6K 0.01% 785
2019
Q1
$19K Hold
137
﹤0.01% 1093
2018
Q4
$15K Hold
137
﹤0.01% 1109
2018
Q3
$18K Sell
137
-15
-10% -$1.85K ﹤0.01% 1147
2018
Q2
$17K Buy
+152
New +$16.4K ﹤0.01% 1156

Other funds holding CRL

Flagship Harbor Advisors's CRL Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 70 shares — an estimated $14K sold.

Flagship Harbor Advisors first reported a position in CRL in Q2 2018 and held it in 19 quarters. The position peaked at $445K in Q1 2024. 559 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 70 Charles River Laboratories shares in Q1 2026, an estimated $14K.
  • Flagship Harbor Advisors first reported a position in Charles River Laboratories in Q2 2018 and held it in 19 quarters.
  • Flagship Harbor Advisors's Charles River Laboratories position peaked at $445K in Q1 2024.
  • 559 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.